Prophylactic anticoagulant therapy is associated with improved survival in ICU patients with non-COVID-19 pneumonia: a retrospective cohort study
Our results support the potential value of prophylactic anticoagulation therapy as a strategy to improve survival in ICU patients with non-COVID-19 pneumonia.
Authors
- Lokesh Kumar Sharma (ORCID: https://orcid.org/0000-0003-3040-9029)
- Xiangwen Zeng
- Lijuan Zhao
- Rong Hu (ORCID: https://orcid.org/0000-0002-3039-0498)
- Yixing Zhu (ORCID: https://orcid.org/0000-0003-3857-4061)
- Rui Qiu (ORCID: https://orcid.org/0000-0001-5380-0616)
- De Chang (ORCID: https://orcid.org/0000-0001-9767-6901)
- Xue Wu (ORCID: https://orcid.org/0000-0001-6645-2008)
- Haiming Hu
- Yonghong Nie (ORCID: https://orcid.org/0009-0003-6421-1560)
Institutions
- University of Pittsburgh (US)
- Chinese PLA General Hospital (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fphar.2025.1597885
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Nova Program
- National Key Research and Development Program of China